![Jeffrey Sherman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Sherman
Direktor/Vorstandsmitglied bei
LARIMAR THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.07.2026
Profil
Derzeit bekleidet Jeffrey W. Sherman die Position des Chief Medical Officer & Executive Vice President bei Horizon Therapeutics Plc und des Chief Medical Officer & EVP-Regulatory Affairs bei Horizon Therapeutics USA, Inc. (eine Tochtergesellschaft von Horizon Therapeutics Plc). Jeffrey W. Sherman ist außerdem Mitglied des Vorstands von Xeris Pharmaceuticals, Inc. und Strongbridge Biopharma Plc sowie Mitglied des Alumni Board der Feinberg School of Medicine. Zuvor war er Mitglied des American Board of Internal Medicine, Chief Medical Officer & Executive Vice President bei NeoPharm, Inc. und Chief Medical Officer, SVP-Research & Development bei IDM Pharma, Inc. sowie Vice President-Clinical Science bei Takeda Global Research & Development Center, Inc. und Chief Medical Officer & EVP-Regulatory Affairs bei Horizon Pharma, Inc, Head-Oncology Global Medical Operations bei Pharmacia Corp, Chief Marketing Officer & Executive Vice President bei Hyperion Therapeutics, Inc, President & Director bei Drug Information Association, Research Associate bei Howard Hughes Medical Institute, Inc. und Mitglied des National Board of Medical Examiners, Inc. Jeffrey W. Sherman promovierte an der Chicago Medical School und erwarb einen Bachelor-Abschluss am Lake Forest College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2026 | 174.588 ( 0,1 % ) | 1 Mio $ | 31.07.2026 | |
| 19.05.2026 | 5.000 ( 0,01 % ) | 19 100 $ | 31.07.2026 |
Aktuelle Nachrichten zu Jeffrey Sherman
Aktive Positionen von Jeffrey Sherman
| Unternehmen | Position | Beginn |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.10.2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
Feinberg School of Medicine
 Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jeffrey Sherman
| Unternehmen | Position | Ende |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Direktor/Vorstandsmitglied | 04.06.2026 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
Horizon Therapeutics USA, Inc.
 Horizon Therapeutics USA, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief arthritis | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Direktor/Vorstandsmitglied | 05.10.2021 |
| STRONGBRIDGE BIOPHARMA | Direktor/Vorstandsmitglied | 01.10.2021 |
Ausbildung von Jeffrey Sherman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
22
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 22 |
|---|---|
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology Provides drug research, development and commercialization services | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Lake Forest College
 Lake Forest College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
American Board of Internal Medicine
 American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services Operates self-appointed physician evaluation organization | Commercial Services |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Commercial Services |
The National Board of Medical Examiners, Inc.
 The National Board of Medical Examiners, Inc. Medical/Nursing ServicesHealth Services Provides high-quality examinations for the health professions | Health Services |
Takeda Global Research & Development Center, Inc. | |
Center for Healthcare Innovation | |
Horizon Pharma, Inc.
 Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines for the treatment of chronic inflammatory diseases | Health Technology |
Horizon Therapeutics USA, Inc.
Horizon Therapeutics USA, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief arthritis | Health Technology |
Feinberg School of Medicine
Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
 Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for rare diseases | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Sorriso Pharmaceuticals, Inc.
 Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company advancing disease-modifying antibodies for the treatment of inflammatory disease | Health Technology |
